Medical Information Technology, Inc.: 10-Q filed 2020-10-26
What Medical Information Technology, Inc. reported in its quarterly report filed 2020-10-26 (fiscal Q3 2020): 25 published measures, 62 facts as tagged in accession 0001011452-20-000028.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-10-26
- Fiscal period
- fiscal Q3 2020
- Accession
- 0001011452-20-000028 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Medical Information Technology, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 655,133,290 | USD | |
| At 2019-12-31 | 669,475,349 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 117,628,928 | USD | |
| At 2019-12-31 | 111,724,941 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 537,504,362 | USD | |
| At 2019-12-31 | 557,750,408 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 50,134,888 | USD | |
| At 2019-12-31 | 14,997,613 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 30,622,894 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 37,771,687 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 90,796,290 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 143,259,267 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 85,931,281 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 56,344,040 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -2,864,929 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -4,556,569 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 114,721,343 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 373,333,425 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 121,205,017 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 356,519,593 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -58,017,733 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -62,480,634 | USD | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 5,654,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 476,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 22,044,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 32,868,000 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 161,652,696 | USD | |
| At 2019-12-31 | 167,771,137 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 16,165,644 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 63,625,890 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 12,882,334 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 38,567,963 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 478,780,335 | USD | |
| At 2019-12-31 | 487,350,177 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 83,981,721 | USD | |
| At 2019-12-31 | 67,362,185 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 374,919 | USD | |
| At 2019-12-31 | 211,391 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 44,447,421 | USD | |
| At 2019-12-31 | 36,575,028 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 98,555,699 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 309,707,535 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 108,322,683 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 317,951,630 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 37,165,854 | shares | |
| At 2019-12-31 | 37,165,854 | shares |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 143,764,814 | USD | |
| At 2019-12-31 | 138,527,057 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 7,105,342 | USD | |
| At 2019-12-31 | 7,193,998 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 16,051,628 | USD | |
| At 2019-12-31 | 17,411,282 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 30,858,218 | USD | |
| At 2019-12-31 | 24,327,709 | USD |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 8,983,370 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 10,405,170 | USD | 273 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 771,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -62,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 5,198,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 5,554,000 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 163,528 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -143,154 | USD | 273 |
Inspect the source
- Entity
- Medical Information Technology, Inc. / CIK 0001011452
- Captured
- SEC response SHA-256
f572256ab4fe6ce457b78b55993c7ccf2bc707c899228e299af4f26f0d61ed75
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001011452.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))